1. Home
  2. INTS vs AGAE Comparison

INTS vs AGAE Comparison

Compare INTS & AGAE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INTS
  • AGAE
  • Stock Information
  • Founded
  • INTS 2012
  • AGAE 2017
  • Country
  • INTS United States
  • AGAE United States
  • Employees
  • INTS N/A
  • AGAE N/A
  • Industry
  • INTS Biotechnology: Pharmaceutical Preparations
  • AGAE Cable & Other Pay Television Services
  • Sector
  • INTS Health Care
  • AGAE Telecommunications
  • Exchange
  • INTS Nasdaq
  • AGAE Nasdaq
  • Market Cap
  • INTS 33.4M
  • AGAE 50.8M
  • IPO Year
  • INTS 2023
  • AGAE N/A
  • Fundamental
  • Price
  • INTS $2.20
  • AGAE $1.09
  • Analyst Decision
  • INTS Strong Buy
  • AGAE
  • Analyst Count
  • INTS 3
  • AGAE 0
  • Target Price
  • INTS $8.50
  • AGAE N/A
  • AVG Volume (30 Days)
  • INTS 40.1K
  • AGAE 24.3K
  • Earning Date
  • INTS 03-13-2025
  • AGAE 03-26-2025
  • Dividend Yield
  • INTS N/A
  • AGAE N/A
  • EPS Growth
  • INTS N/A
  • AGAE N/A
  • EPS
  • INTS N/A
  • AGAE N/A
  • Revenue
  • INTS N/A
  • AGAE $9,256,023.00
  • Revenue This Year
  • INTS N/A
  • AGAE N/A
  • Revenue Next Year
  • INTS N/A
  • AGAE N/A
  • P/E Ratio
  • INTS N/A
  • AGAE N/A
  • Revenue Growth
  • INTS N/A
  • AGAE 36.15
  • 52 Week Low
  • INTS $1.50
  • AGAE $0.61
  • 52 Week High
  • INTS $5.94
  • AGAE $1.57
  • Technical
  • Relative Strength Index (RSI)
  • INTS 54.20
  • AGAE 66.14
  • Support Level
  • INTS $2.00
  • AGAE $1.03
  • Resistance Level
  • INTS $2.37
  • AGAE $1.17
  • Average True Range (ATR)
  • INTS 0.31
  • AGAE 0.06
  • MACD
  • INTS -0.00
  • AGAE 0.01
  • Stochastic Oscillator
  • INTS 48.24
  • AGAE 80.06

About INTS Intensity Therapeutics Inc. Common stock

Intensity Therapeutics Inc is a clinical-stage biotechnology company pioneering a new immune-based approach to treat solid tumor cancers. The company leverages its DfuseRxtechnology platform to create new, proprietary drug formulations that, following direct injection, rapidly disperse throughout a tumor and diffuse therapeutic agents into cancer cells. Intensity's product candidates have the potential to induce an adaptive systemic immune response that not only attacks the injected tumor, but also non-injected tumors. Their pipeline is focused on realizing the full potential of INT230-6 in metastatic and local disease settings to help cancer patients with major unmet medical need.

About AGAE Allied Gaming & Entertainment Inc.

Allied Gaming & Entertainment Inc is an experiential entertainment company focused on providing a growing world of gamers with various experiences through renowned assets, products, and services.

Share on Social Networks: